May. 7 at 8:26 PM
$MRVI Q1 '26 Earnings Results & Recap
• Reported GAAP EPS of -
$0.02 up 90.48% YoY
• Reported revenue of
$65.84M up 40.53% YoY
• Maravai LifeSciences increased its full year 2026 revenue guidance to
$205M to
$215M, up from prior. Adjusted EBITDA guidance was also raised to
$30M to
$32M for 2026.
